IAFFALDANO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 284
EU - Europa 87
AS - Asia 46
OC - Oceania 1
Totale 418
Nazione #
US - Stati Uniti d'America 282
SE - Svezia 30
IT - Italia 26
CN - Cina 21
SG - Singapore 20
DE - Germania 5
FI - Finlandia 5
BE - Belgio 4
GB - Regno Unito 4
RU - Federazione Russa 3
VN - Vietnam 3
CA - Canada 2
LT - Lituania 2
UA - Ucraina 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
FR - Francia 1
IE - Irlanda 1
IN - India 1
IS - Islanda 1
MK - Macedonia 1
Totale 418
Città #
Fairfield 45
Chandler 38
Woodbridge 36
Ashburn 25
Cambridge 22
Nyköping 20
Singapore 18
Seattle 16
Houston 15
Wilmington 12
Ann Arbor 10
Bari 10
Beijing 9
Helsinki 5
Brooklyn 4
Brussels 4
Lawrence 4
Roxbury 4
Dong Ket 3
Munich 3
Bisceglie 2
Frankfurt am Main 2
Gravina in Puglia 2
Guangzhou 2
Los Angeles 2
Lviv 2
Santa Clara 2
Brno 1
Chicago 1
Dalian 1
Des Moines 1
Dhaka 1
Dublin 1
Guiyang 1
Hamilton 1
Hebei 1
Imbersago 1
Jinhua 1
Keflavik 1
Melbourne 1
Middlesex 1
Milan 1
Mottola 1
Norwalk 1
Paris 1
Pune 1
San Diego 1
Shanghai 1
Shenyang 1
Sofia 1
Torino 1
Toronto 1
Washington 1
Totale 343
Nome #
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 109
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register 101
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 96
null 44
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis 28
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study 27
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 16
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments 12
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 7
Totale 440
Categoria #
all - tutte 2.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 0 0 14 18 17 14 14 7
2020/202160 3 9 3 6 6 6 3 4 3 9 3 5
2021/202259 11 1 0 4 4 11 1 3 2 3 5 14
2022/202386 9 14 8 8 9 9 1 11 10 0 4 3
2023/202439 6 6 0 7 7 4 1 1 1 4 0 2
2024/202557 8 1 17 8 12 11 0 0 0 0 0 0
Totale 440